Ketamine for Treatment Resistant Depression
APSKC is currently offering ketamine infusions for Treatment Resistant Depression. When effective, ketamine may alleviate depressive symptoms within a matter of hours or days. Ketamine received Food and Drug Administration (FDA) approval for use as an anesthetic in 1970. Ketamine has been well-studied for more than ten years an “off-label” procedure for treating depression. Off-label means that while the Food and Drug Administration (FDA) has not approved Ketamine as a safe and effective treatment for depression, it is both ethical and legal for trained and licensed professionals to administer ketamine for depression based on research evidence and clinical experience compiled since its approval as an anesthetic. Before the opening of the APSKC Ketamine Clinic in December 2016, Kansas City area patients sought ketamine treatments in clinics on the East and West Coasts, Denver, Texas, and other distant locations. After extensive review and discussion of the subject, our group made the commitment to providing the highest levels of effective and safe administration of ketamine for depression, including mechanisms for monitoring patient progress and modifying our treatment protocols, as the state-of-the-art progresses.